De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Shenzhen Goodix Technology Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Shenzhen Goodix Technology has a total shareholder equity of CN¥8.4B and total debt of CN¥630.0M, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are CN¥10.0B and CN¥1.6B respectively. Shenzhen Goodix Technology's EBIT is CN¥528.5M making its interest coverage ratio -4.1. It has cash and short-term investments of CN¥4.6B.
Belangrijke informatie
7.5%
Verhouding schuld/eigen vermogen
CN¥629.98m
Schuld
Rente dekkingsratio | -4.1x |
Contant | CN¥4.56b |
Aandelen | CN¥8.36b |
Totaal verplichtingen | CN¥1.62b |
Totaal activa | CN¥9.97b |
Recente financiële gezondheidsupdates
Recent updates
Shenzhen Goodix Technology (SHSE:603160) Will Be Hoping To Turn Its Returns On Capital Around
Sep 11Shenzhen Goodix Technology (SHSE:603160) Seems To Use Debt Rather Sparingly
Aug 05Shenzhen Goodix Technology Co., Ltd.'s (SHSE:603160) Popularity With Investors Is Under Threat From Overpricing
Jul 17Shenzhen Goodix Technology (SHSE:603160) May Have Issues Allocating Its Capital
Jun 10Shareholders Will Be Pleased With The Quality of Shenzhen Goodix Technology's (SHSE:603160) Earnings
Apr 17Shenzhen Goodix Technology Co., Ltd. (SHSE:603160) Stock Rockets 29% As Investors Are Less Pessimistic Than Expected
Mar 04Analyse van de financiële positie
Kortlopende schulden: 603160's short term assets (CN¥5.8B) exceed its short term liabilities (CN¥1.3B).
Langlopende schulden: 603160's short term assets (CN¥5.8B) exceed its long term liabilities (CN¥339.2M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 603160 has more cash than its total debt.
Schuld verminderen: 603160's debt to equity ratio has increased from 0.6% to 7.5% over the past 5 years.
Schuldendekking: 603160's debt is well covered by operating cash flow (215.8%).
Rentedekking: 603160 earns more interest than it pays, so coverage of interest payments is not a concern.